Module

Antiretroviral Strategies for Minimizing Cardiovascular Risk

Source: Managing Cardiovascular Risk in HIV-Infected Patients: The Role of Antiretroviral Selection

Antiretroviral Strategies for Minimizing Cardiovascular Risk


Faculty:

  • Sally Hodder, MD

CME CREDIT INFORMATION

Release Date: 12/12/07

Expiration Date: 12/11/08


Physicians: maximum of 2.5 AMA PRA Category 1 Credit(s)

Pharmacists: 2.5 contact hours (0.25 CEUs)

Registered Nurses: 2.5 Nursing CE credits

Status: Please log in to view status



Learning Objectives

Upon completion of this activity, participants should be able to:

  • Summarize the guidelines on cardiovascular risk management in HIV settings
  • Explain the benefits and limitations of lipid-lowering therapy in HIV-infected patients
  • Discuss data concerning the selection of antiretrovirals to minimize cardiovascular risk
  • Identify antiretroviral therapy modification strategies to reduce cardiovascular risk

Topics covered include:

  • Introduction
  • Evaluation and Management of Cardiovascular Risk: Current Guidelines
  • Modification of Lifestyle
  • Selecting Antiretrovirals to Minimize CVD Risk: Initial Regimen
  • Effect of Antiretroviral Agents on Lipids
  • The Comparative Effects of Boosted PI Regimens on Lipids
  • Comparing the Lipid Effects of PI, NNRTI, and NRTI-Sparing Regimens
  • Comparing the Lipid Effects of NNRTI-Based Regimens
  • Comparing the Lipid Effects of NRTIs
  • Modifying Antiretroviral Therapy to Minimize CVD Risk
  • Use of Lipid-Lowering Therapy in HIV-Infected Patients
  • Summary: Implications for Clinical Practice


Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Medical Education Collaborative and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.